Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,802.50
-32.50 (-1.15%)
Sep 10, 2026, 3:30 PM JST
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 633.26 billion as of September 10, 2026. Its market cap has increased by 8.92% in one year.
Market Cap
633.26B
Enterprise Value
625.56B
Revenue
353.39B
Ranking
n/a
PE Ratio
19.94
Stock Price
2,802.50
ChartMarket Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 633.26B, an increase of 875.06%. That is a compound annual growth rate of 8.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 633.26B | 6.64% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kao Corporation | 3.09T |
| Unicharm | 1.66T |
| Shiseido Company | 1.34T |
| Lion Corporation | 500.41B |
| Kobayashi Pharmaceutical | 439.56B |
| MTG Co., Ltd. | 325.48B |
| KOSE Holdings | 320.64B |
| Pola Orbis Holdings | 297.40B |